Cargando…
TRIM59 Is a Novel Marker of Poor Prognosis and Promotes Malignant Progression of Ovarian Cancer by Inducing Annexin A2 Expression : Erratum
Autores principales: | Wang, You, Zhou, Zhicheng, Wang, Xinran, Zhang, Xuping, Chen, Yansu, Bai, Jin, Di, Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771837/ https://www.ncbi.nlm.nih.gov/pubmed/35173536 http://dx.doi.org/10.7150/ijbs.69329 |
Ejemplares similares
-
TRIM59 Is a Novel Marker of Poor Prognosis and Promotes Malignant Progression of Ovarian Cancer by Inducing Annexin A2 Expression
por: Wang, You, et al.
Publicado: (2018) -
Overexpression of TC2N is associated with poor prognosis in gastric cancer: Erratum
por: Xu, Jianbo, et al.
Publicado: (2022) -
Erratum to: JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer
por: Lee, Yi Fang, et al.
Publicado: (2017) -
Erratum to the important roles and molecular mechanisms of annexin A(2) autoantibody in children with nephrotic syndrome
Publicado: (2023) -
High Expression of Cancer-Derived Glycosylated Immunoglobulin G Predicts Poor Prognosis in Pancreatic Ductal Adenocarcinoma: Erratum
por: Cui, Ming, et al.
Publicado: (2021)